The Nrf2 inhibitor ML385 blocks the beneficial effects of quercetin on DCM, suggesting that quercetin improves DCM by promoting Nrf2 nuclear translocation and increasing the expression of antioxidant factors such as HO-1 (Zhang et al., 2022). The gene discussed is HMOX1; the disease is familial dilated cardiomyopathy.